Jiapei Li, Weigang Zhao, T. Yuan, Yong Fu, Ying-yue Dong, Juan Li
{"title":"Long-term outcome of postpartum glucose metabolism among patients with gestational hyperglycemia and its risk factors","authors":"Jiapei Li, Weigang Zhao, T. Yuan, Yong Fu, Ying-yue Dong, Juan Li","doi":"10.3760/CMA.J.ISSN.1674-635X.2019.02.002","DOIUrl":null,"url":null,"abstract":"Objective \nTo explore the long-term outcome of postpartum glucose metabolism among patients with gestational hyperglycemia and its risk factors. \n \n \nMethods \nPatients with gestational hyperglycemia, diagnosed by 100 g oral glucose tolerance test(OGTT) during 24th to 28th gestation week between 2010 and 2012 and giving the childbirth in Peking Union Medical College Hospital, were included. The glucose metabolism outcomes were evaluated by 75 g OGTT. The risk factors influencing the glucose metabolism outcome and the glucose metabolism parameter changes between the pregnancy term and now were also analyzed. \n \n \nResults \nForty patients with gestational hyperglycemia were included. The follow-up time was postpartum 5-8 years and (6.83±0.74)years on average. Among them, 3 patients were diagnosed with type 2 diabetes and 9 patients were diagnosed with impaired glucose intolerance. The overall rate of abnormal glucose metabolism was 30 percent. The third-hour glucose of OGTT larger than 7.45 mmol/L and the area under the glucose curve(Glu AUC) during OGTT larger than 24.875 mmol×h/L were the risk factors for the abnormal glucose metabolism outcome, with the odds ratio of 5.769 (95% confidence interval 1.064-31.270, P=0.042) and 12.5(95% confidence interval 2.226-70.187, P=0.004). Using the 2-hour glucose larger than 8.25 mmol/L and 3-hour glucose larger than 7.45 mmol/L in the OGTT of midtrimester to judge the glucose state in the follow-up visit can achieve the diagnostic efficacy with the sensitivity of 75%, specificity of 82%, positive prediction value of 64% and negative prediction value of 88%. Comparing with now, the fasting glucose in the midtrimester was lower ([5.49±0.43] vs. [4.55±0.47] mmol/L, P<0.001), the fasting insulin in the midtrimester was higher (12.30[6.35, 16.55] vs. 8.31[6.79, 12.00] μIU/ml, P=0.048), HOMA-β in the midtrimester was higher (202.67[145.71, 335.71] vs. 85.41[78.63, 112.13], P<0.001). \n \n \nConclusion \nThe third-hour glucose larger than 7.45 mmol/L and the glucose area under the curve larger than 24.88 mmol×h/L in the OGTT of midtrimester are the risk factors for the abnormal glucose state in the postpartum long-term follow-up. The combination of the second-hour and the third-hour glucoses in the 100 g OGTT of midtrimester can help to predict the postpartum long-term glucose state. \n \n \nKey words: \ngestational hyperglycemia; postpartum long-term glucose metabolism","PeriodicalId":9877,"journal":{"name":"中华临床营养杂志","volume":"27 1","pages":"70-75"},"PeriodicalIF":0.0000,"publicationDate":"2019-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华临床营养杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1674-635X.2019.02.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Nursing","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
To explore the long-term outcome of postpartum glucose metabolism among patients with gestational hyperglycemia and its risk factors.
Methods
Patients with gestational hyperglycemia, diagnosed by 100 g oral glucose tolerance test(OGTT) during 24th to 28th gestation week between 2010 and 2012 and giving the childbirth in Peking Union Medical College Hospital, were included. The glucose metabolism outcomes were evaluated by 75 g OGTT. The risk factors influencing the glucose metabolism outcome and the glucose metabolism parameter changes between the pregnancy term and now were also analyzed.
Results
Forty patients with gestational hyperglycemia were included. The follow-up time was postpartum 5-8 years and (6.83±0.74)years on average. Among them, 3 patients were diagnosed with type 2 diabetes and 9 patients were diagnosed with impaired glucose intolerance. The overall rate of abnormal glucose metabolism was 30 percent. The third-hour glucose of OGTT larger than 7.45 mmol/L and the area under the glucose curve(Glu AUC) during OGTT larger than 24.875 mmol×h/L were the risk factors for the abnormal glucose metabolism outcome, with the odds ratio of 5.769 (95% confidence interval 1.064-31.270, P=0.042) and 12.5(95% confidence interval 2.226-70.187, P=0.004). Using the 2-hour glucose larger than 8.25 mmol/L and 3-hour glucose larger than 7.45 mmol/L in the OGTT of midtrimester to judge the glucose state in the follow-up visit can achieve the diagnostic efficacy with the sensitivity of 75%, specificity of 82%, positive prediction value of 64% and negative prediction value of 88%. Comparing with now, the fasting glucose in the midtrimester was lower ([5.49±0.43] vs. [4.55±0.47] mmol/L, P<0.001), the fasting insulin in the midtrimester was higher (12.30[6.35, 16.55] vs. 8.31[6.79, 12.00] μIU/ml, P=0.048), HOMA-β in the midtrimester was higher (202.67[145.71, 335.71] vs. 85.41[78.63, 112.13], P<0.001).
Conclusion
The third-hour glucose larger than 7.45 mmol/L and the glucose area under the curve larger than 24.88 mmol×h/L in the OGTT of midtrimester are the risk factors for the abnormal glucose state in the postpartum long-term follow-up. The combination of the second-hour and the third-hour glucoses in the 100 g OGTT of midtrimester can help to predict the postpartum long-term glucose state.
Key words:
gestational hyperglycemia; postpartum long-term glucose metabolism
期刊介绍:
The Chinese Journal of Clinical Nutrition was founded in 1993. It is the first professional academic journal (bimonthly) in my country co-sponsored by the Chinese Medical Association and the Chinese Academy of Medical Sciences to disseminate information on clinical nutrition support, nutrient metabolism, the impact of nutrition support on outcomes and "cost-effectiveness", as well as translational medicine and nutrition research. It is also a professional journal of the Chinese Medical Association's Parenteral and Enteral Nutrition Branch.
The purpose of the Chinese Journal of Clinical Nutrition is to promote the rapid dissemination of knowledge on nutrient metabolism and the rational application of parenteral and enteral nutrition, focusing on the combination of multidisciplinary and multi-regional field investigations and clinical research. It mainly reports on nutritional risk screening related to the indications of parenteral and enteral nutrition support, "cost-effectiveness" research on nutritional drugs, consensus on clinical nutrition, guidelines, expert reviews, randomized controlled studies, cohort studies, glycoprotein and other nutrient metabolism research, systematic evaluation of clinical research, evidence-based case reports, special reviews, case reports and clinical experience exchanges, etc., and has a special column on new technologies related to the field of clinical nutrition and their clinical applications.